Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Blood-Cleaning therapy may reduce need for ICU pressor drugs

NCT ID NCT07679555

Knowledge-focused Sponsor: Pest County Flór Ferenc Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 01, 2026 · Last updated Jul 08, 2026 · Updated 3 times

Summary

This study looks back at medical records of 60 critically ill adults in an intensive care unit who received a blood-cleaning treatment called hemoadsorption. The goal is to see if the therapy helps lower the need for drugs that raise blood pressure, improves lab results, and affects survival. The study does not give any new treatment—it simply analyzes data from routine care.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Hemoadsorption (CytoSorb or Efferon LPS cartridge)
What this could lead to
If results are positive, this could point toward a way to reduce the need for blood-pressure-raising drugs in critically ill patients.
What could go wrong
This is a small, single-center observational study, so it cannot prove cause and effect. The therapy may not work for everyone, and results may not apply to other hospitals.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 60 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jan 2020

Expected to finish

Sep 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The study will be retrospective. Patients who received adjunctive hemoadsorption therapy at the Department of Anesthesiology and Intensive Care of Flór Ferenc Hospital between January 1, 2020, and May 31, 2026, will be included in the study.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * \>18 years; * CytoSorb or Efferon LPS hemoadsorption treatment, * with available relevant pre- and post-treatment clinical and laboratory data Exclusion Criteria: * age under 18 years * missing key demographic or outcome data; * unknown treatment type or timing; * data unavailable for legal or ethical reasons.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hemoadsorption are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

infectious disease with sepsis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Hemoadsorption Vasopressor therapy

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Pest County Flór Ferenc Hospital, Dept. of Anaesthesiology and Intensive Therapy

    RECRUITING

    Kistarcsa, Pest County, 2143, Hungary

More trials for these conditions

Other studies related to the condition(s) this trial covers.